Stroke.med.kyushu-u.ac.jp

19th European Stroke Conference, Barcelona, Effect of cilostazol for progressive stroke.
19th European Stroke Conference, Barcelona, deterioration in the acute phase of ischemic Koga M, Endo K, Sakai N, Yamagami H,Furui E, Matsumoto Y, Shiokawa Y,Yoshimura S, Okada Y, Hyogo T, Characteristics of acute stroke patients with major artery occlusion who did not receive Toyoda K, Joint research group from JR-NET2 and SAMURAI study investigatorsFujimoto S, Jinnouchi J, Suzuki S, Inoue Effect of combined antithrombotic treatment with cilostazol for progressive stroke.
Flow velocity of left atrial appendage is associated with stroke severity and clinical outcome in patients with atrial fibrillation.
Acute blood pressure variability is associated with clinical outcome in acute stroke patients Endo K, Koga M, Sakai N, Yamagami H,Furui E, Matsumoto Y, Shiokawa Y,Yoshimura S, Okada Y, Hasegawa Y, Etiology, clinical profiles, treatment, and outcomes of acute ischemic stroke with major 2010, 10 Terada T, Minematsu K, Toyoda K, Joint cerebral artery occlusion in Japan.
research group form JR-NET2 andSAMURAI study investigatorsSuzuki R, Koga M, Shono Y, Torii T, Niki Intermittent pneumatic compression to prevent 7th World Stroke Congress, Seoul, Korea, deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage.
Ischemic stroke recurrence in the middle of Matsumoto M, Yamawaki T, OhtsukiM,Fukushima Y, Nagai K, Minematsu K, Nox4 is a major source of ROS in the failing Effects of pre-stroke antihypertensive agents International Stroke Conference 2010, San on early prognosis of acute brain ischemia: Koga M, Naganuma M, Shiokawa Y,Nakagawara J, Furui E, Kimura K, Low-dose intravenous rt-PA therapy for stroke International Stroke Conference 2010, San patients out of the indications by the European Antonio, USA, 2010, 2 Minematsu K, Toyoda KKoga M, Kimura K, Shibasaki K, International Stroke Conference 2010, San favorable clinical outcome after intravenous rt- PA therapy in stroke patients with AF.
Kario K, Okuda S, Naganuma M,Yoshimura S, Sugimori H , Ago T, Clinical features of cryptogenic brain infarction International Stroke Conference 2010, San –the Fukuoka Stroke Registry (FSR)-.
Predictors of acute clinical deterioration in International Stroke Conference 2010, San stroke patients receiving intravenous low-dose rt-PA: a multicenter observational study.
K, Okuda S, Koga M, Minematsu K,Naganuma M, Koga M, Shiokawa Y, Reduced estimated glomerular filtration rate is associated with intracranial hemorrhage and International Stroke Conference 2010, San Nezu T, Koga M, Kimura K, Shiokawa Y, Pre-treatment DWI-ASPECTS is superior to International Stroke Conference 2010, San CT-ASPECTS in detecting excellent to fairly good outcome after intravenous rt-PA therapy.
S, Naganuma M, Minematsu K, Toyoda KNezu T, Koga M, Kimura K, Shiokawa Y, Pre-treatment DWI-ASPECTS score has a International Stroke Conference 2010, San relation with functional outcome at 3 months following intravenous rt-PA therapy.
intracranial hemorrhage and stroke outcome Nakagawara J, Furui E, Kimura K, Okada after intravenous thrombolysis: the Stroke International Stroke Conference 2010, San Assessment and Improvement (SAMURAI)Study.
Lower CHADS2 score is associated with XVIIII. European Stroke Conference, Barcelona, favorable clinical outcomes in acute stroke XVIIII. European Stroke Conference, Barcelona, Stroke recurrence in embolic stroke. <poster> Visualization of the lesser sphenoid wing on B- XVIIII. European Stroke Conference, Barcelona, cerebral artery by transcranial color-coded Hemorrhagic transformation associated with XVIIII. European Stroke Conference, Barcelona, plasminogen activator therapy in Japanese patients from the SAMURAI rt-PA registry.

Source: http://www.stroke.med.kyushu-u.ac.jp/files/2013/06/2010_g.pdf